Philip Morris International (Philip Morris International) COGS-to-Revenue

: 0.38 (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

Philip Morris International's Cost of Goods Sold for the three months ended in Dec. 2023 was $3,462 Mil. Its Revenue for the three months ended in Dec. 2023 was $9,047 Mil.

Philip Morris International's COGS to Revenue for the three months ended in Dec. 2023 was 0.38.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Philip Morris International's Gross Margin % for the three months ended in Dec. 2023 was 61.73%.

Philip Morris International COGS-to-Revenue Historical Data

The historical data trend for Philip Morris International's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philip Morris International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.35

0.33

0.32

0.36

0.37

Philip Morris International Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.39	0.38	0.36	0.35	0.38

Philip Morris International COGS-to-Revenue Calculation

Philip Morris International's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	12893	/	35174
	=	0.37

Philip Morris International's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3462	/	9047
	=	0.38

Philip Morris International (NYSE:PM) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Philip Morris International's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	3462 / 9047
	=	61.73 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Philip Morris International COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Philip Morris International's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Philip Morris International (Philip Morris International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » Philip Morris International Inc (NYSE:PM) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

PM:Mexico 1PM:Italy 0M8V:UK 4I1:Germany 4I1:Germany 4I1:Germany PMI:Switzerland PHMO34:Brazil PMOR:Austria

Address

677 Washington Boulevard, Suite 1100, Stamford, Connecticut, New York, NY, USA, 06901

Website

https://www.pmi.com

Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from cigarettes with the 2022 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches, primarily in the U.S. and Scandinavia. It diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.

Executives

Wilde Frederic De	officer: Sr. VP, Marketing & Sales	120 PARK AVENUE, NEW YORK NY 10017
Yann Guerin	officer: SVP & Global Head of L&C	677 WASHINGTON BLVD., SUITE 1100, STAMFORD CT 06901
Werner Barth	officer: Sr. VP, Marketing and Sales	120 PARK AVENUE, NEW YORK NY 10017
Lars Dahlgren	officer: Pres. Smoke-Free Oral Products	677 WASHINGTON BLVD., STAMFORD CT 06896
Dessislava Temperley	director	C/O CIMPRESS PLC, 275 WYMAN STREET, WALTHAM MA 02451
Reginaldo Dobrowolski	officer: Vice President and Controller	677 WASHINGTON BLVD, SUITE 1100, STAMFORD CT 06901
Martin G. King	officer: SVP Operations	120 PARK AVENUE, NEW YORK NY 10017
Paul Riley	officer: Pres East Asia & Australia	120 PARK AVENUE, NEW YORK NY 10017
Drago Azinovic	officer: Pres., European Union Region	120 PARK AVENUE, NEW YORK NY 10017
Mario Masseroli	officer: Pres., Latin America & Canada	120 PARK AVENUE, NEW YORK NY 10017
Juan J. Daboub	director	5100 W. 115TH PLACE, LEAWOOD KS 66211
Shlomo Yanai	director	ONE MEADOWLANDS PLAZA, EAST RUTHERFORD NJ 07073
Stacey Kennedy	officer: Pres. South & Southeast Asia	120 PARK AVENUE, NEW YORK NY 10017
Charles Bendotti	officer: Senior VP, Human Resources	120 PARK AVENUE, NEW YORK NY 10017
Andre Calantzopoulos	director, officer: President & CEO	677 WASHINGTON BLVD, SUITE 1100, STAMFORD CT 06901